Literature DB >> 31226270

Candida auris exhibits resilient biofilm characteristics in vitro: implications for environmental persistence.

B Short1, J Brown1, C Delaney1, L Sherry1, C Williams2, G Ramage1, R Kean3.   

Abstract

Surfaces within healthcare play a key role in the transmission of drug-resistant pathogens. Candida auris is an emerging multidrug-resistant yeast which can survive for prolonged periods on environmental surfaces. Here we show that the ability to form cellular aggregates increases survival after 14 days, which coincides with the upregulation of biofilm-associated genes. Additionally, the aggregating strain demonstrated tolerance to clinical concentrations of sodium hypochlorite and remained viable 14 days post treatment. The ability of C. auris to adhere to and persist on environmental surfaces emphasizes our need to better understand the biology of this fungal pathogen.
Copyright © 2019 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Biofilm; Candida auris; Disinfection; Surface

Year:  2019        PMID: 31226270     DOI: 10.1016/j.jhin.2019.06.006

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  19 in total

1.  A Human Ex Vivo Skin Model to Study Candida auris Biofilms.

Authors:  Dora E Corzo-León; Catherine Mark; Donna M MacCallum; Carol A Munro
Journal:  Methods Mol Biol       Date:  2022

2.  First Report of Candidemia Clonal Outbreak Caused by Emerging Fluconazole-Resistant Candida parapsilosis Isolates Harboring Y132F and/or Y132F+K143R in Turkey.

Authors:  Amir Arastehfar; Farnaz Daneshnia; Suleyha Hilmioğlu-Polat; Wenjie Fang; Melike Yaşar; Furkan Polat; Dilek Yeşim Metin; Petra Rigole; Tom Coenye; Macit Ilkit; Weihua Pan; Wanqing Liao; Ferry Hagen; Markus Kostrzewa; David S Perlin; Cornelia Lass-Flörl; Teun Boekhout
Journal:  Antimicrob Agents Chemother       Date:  2020-09-21       Impact factor: 5.191

3.  Inhibition of Candida auris Biofilm Formation on Medical and Environmental Surfaces by Silver Nanoparticles.

Authors:  Humberto H Lara; Liliana Ixtepan-Turrent; Miguel Jose Yacaman; Jose Lopez-Ribot
Journal:  ACS Appl Mater Interfaces       Date:  2020-01-16       Impact factor: 9.229

Review 4.  Combined Antifungal Resistance and Biofilm Tolerance: the Global Threat of Candida auris.

Authors:  Ryan Kean; Gordon Ramage
Journal:  mSphere       Date:  2019-07-31       Impact factor: 4.389

5.  External Quality Assessment Evaluating the Ability of Dutch Clinical Microbiological Laboratories to Identify Candida auris.

Authors:  Jochem B Buil; Henrich A L van der Lee; Ilse Curfs-Breuker; Paul E Verweij; Jacques F Meis
Journal:  J Fungi (Basel)       Date:  2019-10-07

6.  Candida auris Phenotypic Heterogeneity Determines Pathogenicity In Vitro.

Authors:  Jason L Brown; Chris Delaney; Bryn Short; Mark C Butcher; Emily McKloud; Craig Williams; Ryan Kean; Gordon Ramage
Journal:  mSphere       Date:  2020-06-24       Impact factor: 4.389

Review 7.  Candida auris Urinary Tract Infections and Possible Treatment.

Authors:  Nicole Griffith; Larry Danziger
Journal:  Antibiotics (Basel)       Date:  2020-12-12

Review 8.  Microbial Air Quality in Healthcare Facilities.

Authors:  Lucia Bonadonna; Rossella Briancesco; Anna Maria Coccia; Pierluigi Meloni; Giuseppina La Rosa; Umberto Moscato
Journal:  Int J Environ Res Public Health       Date:  2021-06-09       Impact factor: 3.390

9.  Repositionable Compounds with Antifungal Activity against Multidrug Resistant Candida auris Identified in the Medicines for Malaria Venture's Pathogen Box.

Authors:  Gina Wall; Natalia Herrera; José L Lopez-Ribot
Journal:  J Fungi (Basel)       Date:  2019-10-01

10.  Chitosan Ameliorates Candida auris Virulence in a Galleria mellonella Infection Model.

Authors:  Laís Salomão Arias; Mark C Butcher; Bryn Short; Emily McKloud; Chris Delaney; Ryan Kean; Douglas Roberto Monteiro; Craig Williams; Gordon Ramage; Jason L Brown
Journal:  Antimicrob Agents Chemother       Date:  2020-07-22       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.